The Cur-Tf-PDAAm NPs can enhance cellular uptake and delivery of curcumin to cancer cells through Tf receptor-mediated endocytosis compared to the control NPs (Cur-POEGA-PDAAm) without a targeting protein when tested on MDA-MB-231 breast cancer cells. The gene discussed is TF; the disease is breast carcinoma.